Overall, we provide new molecular insights into the chronification of prostatitis and demonstrate that seminal plasma estradiol levels and epigenetic state of estrogen receptor genes, respectively, may be a novel diagnostic tool for CP/CPPS patients that could be used to select patients for targeted therapy. This evidence concerns the gene ESR1 and male reproductive organ cancer.